-
Inside Novartis’ big bet on creativity to become a world-class marketing team
15 Jul 2025 09:36 GMT
… the underpinning of that.”
Novartis made one of the biggest … in creativity led to Novartis making its Super Bowl … is at the core of Novartis’ event called East Cannesover. … Williams echoed this spirit, celebrating Novartis’ desire to “do something differently …
-
Novartis dealt a blow in patent fight to block Entresto generics
11 Jul 2025 17:24 GMT
-
Neutralizing Antibody Market Exclusive Report With Detailed Analysis Through 2025 - 2032 | Novartis AG, Inc., Sanofi SA
11 Jul 2025 13:36 GMT
…
• Sanofi SA
• Roche Holding AG
• Novartis AG
• Merck & Co.Inc …
-
Novartis Leverages Sports Sponsorships
11 Jul 2025 13:05 GMT
… health and wellness topics.
And Novartis? In addition
to the pharma … -- and only -- break.
Novartis ads are “baked in and … , Dairy Queen, Sony and UBS.)
Novartis declined to speak with Pharma … .
That would play nicely for Novartis, which now has a five …
-
Swissmedic approves Novartis' Coartem Baby to treat malaria in newborns and young infants
10 Jul 2025 05:46 GMT
… Global Health Products procedure. Novartis plans to introduce the … said Vas Narasimhan, CEO of Novartis. “Together with our partners, … infants was developed by Novartis with the scientific and … deaths in the region.
Novartis finds breakthroughs for diseases …
-
Drug manufacturer Novartis gets nod for first malaria drug to treat babies
10 Jul 2025 01:05 GMT
… a breakthrough, drug company Novartis received approval in Switzerland for … and very young children.
Novartis launched Coartem in 1999 … not-for-profit basis, informed Novartis.
"Together with our … they deserve," said Novartis CEO Vas Narasimhan to …
-
Novartis' brain delivery platform option deal worth up to $175M; Neumora's next steps
09 Jul 2025 15:53 GMT
Plus, news about Vie Ventures, Jasper Therapeutics, Jim Wilson’s GEMMABio Therapeutics, Gilead’s lenacapavir, Atsena Therapeutics, Leo Pharma and Cogent Biosciences:
Novartis inks option deal …
-
Breakthrough for babies: Novartis Coartem Baby approved as first Malaria drug for Infants
09 Jul 2025 11:00 GMT
Basel: Novartis has received approval from … for Global Health Products procedure. Novartis plans to introduce the infant … said Vas Narasimhan, CEO of Novartis. “Together with our partners, … young infants was developed by Novartis with the scientific and …
-
Novartis secures Swiss approval for first-ever malaria treatment for infants, newborns
09 Jul 2025 06:54 GMT
… .
Zurich: Pharmaceutical giant Novartis has announced that it … , Mozambique, and Malawi. Novartis introduced Coartem in 1999 for … youngest infants.
According to Novartis, roughly 30 million babies … , age-appropriate treatments.
Novartis has committed to the …
-
Novartis wins approval: First malaria treatment drug for newborns and babies is here
09 Jul 2025 04:15 GMT
… : The ‘Not‑for‑profit’ ethos
Novartis, with the support of Medicines … for the tiniest malaria patients, Novartis and MMV are not only … vaccines – will be critical. Encouragingly, Novartis continues to invest in cutting …
About
© 1995-2025